Hospira, Inc. FDA Inspection Record
Hospira, Inc. is an FDA-registered facility (FEI 1021343) located in Rocky Mount, NC, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK. RegDataLab tracks 12 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Feb 7, 2025: No Action Indicated (NAI)
- Inspections on record
- 12 (3 OAI, 5 VAI, 4 NAI)
- Last OAI inspection
- Nov 15, 2013
- Warning letters
- 1 listed by FDA for this FEI, latest Mar 7, 2014
- Form 483 and inspection documents
- 3 in FDA's reading room
- Recalls as the recalling firm
- 4, latest Jun 15, 2017
- Import refusals
- 2
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Feb 7, 2025 | No Action Indicated (NAI) | No citations listed |
| Nov 21, 2019 | Voluntary Action Indicated (VAI) | Investigations of discrepancies, failures (21 CFR 211.192) Scientifically sound laboratory controls (21 CFR 211.160(b)) Written record of investigation incomplete (21 CFR 211.192) |
| Feb 2, 2018 | Voluntary Action Indicated (VAI) | Calibration/Inspection/Checking not done (21 CFR 211.68(a)) Procedure Deviations Recorded and Justified (21 CFR 211.100(b)) Test devices not meeting specifications (21 CFR 211.160(b)(4)) Documentation (21 CFR 820.100(b)) |
| May 26, 2016 | No Action Indicated (NAI) | No citations listed |
| Sep 24, 2015 | Voluntary Action Indicated (VAI) | No citations listed |
| Jun 13, 2014 | No Action Indicated (NAI) | No citations listed |
| Nov 15, 2013 | Official Action Indicated (OAI) | No citations listed |
| Mar 1, 2013 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Training , Education , Experience overall (21 CFR 211.25(a)) Equipment Design, Size and Location (21 CFR 211.63) Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) and 16 more |
| Aug 4, 2011 | Official Action Indicated (OAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Investigations of discrepancies, failures (21 CFR 211.192) Scientifically sound laboratory controls (21 CFR 211.160(b)) |
| Jun 17, 2011 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Training--operations, GMPs, written procedures (21 CFR 211.25(a)) Buildings of Suitable Size, Construction, Location (21 CFR 211.42(a)) Equipment Design, Size and Location (21 CFR 211.63) and 13 more |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Jun 15, 2017 | Class II | D-1046-2017 | Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also contains: 66 mEq K+ (4.4 mEq/mL) 15… and 3 more products Lack of Sterility Assurance |
| Jan 10, 2013 | Class II | D-169-2013 | Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc… Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial |
| Oct 6, 2006 | Class II | D-390-7 | Lidocaine HCl Injection, USP, 1%, 10mg/ml, 30mL single dose vial, NDC 0409-4279-02, Rx… Product may contain particulates. |
| Jun 18, 2004 | Class II | D-232-4 | 5% Lidocaine HCl and 7.5% Dextrose Injection, USP, 2mL ampul ¿ 5 single ampuls… Some ampuls were found to contain particulates. |
Form 483s and inspection documents
FDA record score
4 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
13 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Nov 21, 2019 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Feb 2, 2018 | 6 x 0.25 | 1.5 |
| Class II recall D-1046-2017, this FEI as the recalling firm | Jun 15, 2017 | 4 x 0.25 | 1 |
| Inspection classified VAI | Sep 24, 2015 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Mar 7, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Nov 15, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Mar 1, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-169-2013, this FEI as the recalling firm | Jan 10, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Aug 4, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jun 17, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Jan 19, 2010 | 10 years or older, so it adds no points | 0 |
| Class II recall D-390-7, this FEI as the recalling firm | Oct 6, 2006 | 10 years or older, so it adds no points | 0 |
| Class II recall D-232-4, this FEI as the recalling firm | Jun 18, 2004 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 22, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
| Warning letter text | Nov 22, 2026 | Newest record Nov 17, 2026 | Current |
| Recalls (Enforcement Report) | Nov 22, 2026 | Newest record Nov 18, 2026 | Current |
| Form 483s and inspection documents | Nov 18, 2026 | Newest record Nov 17, 2026 | Current |
| Import refusals | Nov 22, 2026 | Newest record Nov 12, 2026 | Current |
Reviewing Hospira, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Hospira, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Hospira, Inc.
- Location
- Rocky Mount, NC (US)
- Registration Expires
- Dec 31, 2026
- Operations
- ANALYSIS; LABEL; MANUFACTURE; PACK
- Source
- decrs